Moreover, miR-375 inhibition treatment partly abolished the suppression effects of MLK7-AS1 knockdown on primary ovary tumor growth as well as metastatic tumors in liver and spleen in vivo. Here, MAP3K20 is linked to metastatic neoplasm.